Our Deals
Deals
IMP Logistics Acquired by PRA and Genstar Capital, LLC March 4, 2013
Overview
PRA, a leading clinical research, announced it has acquired privately held ClinStar, LLC, a clinical research organization managing Phase I-IV clinical research trials in the Russian Federation, Ukraine, Belarus and the Baltic Sea.
The acquisition includes ClinStar’s stand-alone clinical trial warehousing and logistics division, IMP Logistics.
Financial terms of the agreement are undisclosed.
Significance
The ClinStar acquisition illustrates PRA’s dedication to support its growth in Russia and Eastern Europe, a region that has proven to be very important to the biopharmaceutical industry.
Through IMP Logistics, PRA is now able to offer its clients top-quality cold chain logistics services that include importation of investigational products, clinical supplies, laboratory kits and printed materials, storage in multiple temperature zones, distribution to sites, collection of returned medication and coordination of product destruction.
This acquisition provides PRA with a significant competitive advantage in a region where central depot services are integral to study success.
Crosstree’s Role
Crosstree Capital Partners served as exclusive financial advisor to ClinStar.